Quantify

Aurora Cannabis Inc. vs Pfizer, Inc. — Stock Comparison

Aurora Cannabis Inc. (ACB) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

vs
Q·Score Winner
Pfizer, Inc.
PFE6.2/10vs 4.4/10

Pfizer, Inc. clearly outscores Aurora Cannabis Inc. on Q·Score (6.2 vs 4.4 out of 10), led by Quality (6.4 vs 2.1) and Valuation (7 vs 3.8). Aurora Cannabis Inc. scores higher on Health, reflecting stronger balance sheet strength. Analysts covering PFE have a consensus price target implying +12.6% from current levels.

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
● ACB● PFE

Q·Score Breakdown

4.4
Bearish
Overall
6.2
Neutral
2.1
Quality
6.4
7.7
Health
7
3.7
Growth
5.1
3.8
Valuation
7
5.6
Sentiment
5.3
ACB

Clean balance sheet with low leverage (0.0× debt-to-equity).

⚠ currently unprofitable (-42% margin).

PFE

Consistently beats earnings estimates (4/4 quarters).

⚠ earnings contracting 10% year-over-year.

Analyst Consensus

Neutral
0 analysts
Neutral
+12.6%
Target $29.19
27 analysts

Fundamentals

ACB
PFE
—
Trailing P/E
19.8×
-26.5×
Forward P/E
9.2×
-42.41%
Profit Margin
11.83%
42.62%
Gross Margin
74.80%
-10.46%
ROE
8.31%
5.10%
Revenue Growth
5.40%
—
Earnings Growth
-10.10%
1.34
Beta
0.29
—
Dividend Yield
6.61%
$181M
Market Cap
$147.7B
52-Week Range
ACB
$35% of range$7
PFE
$2350% of range$29

Frequently Asked Questions

ACB vs PFE: which stock scores better overall?

Based on Q·Score, Pfizer, Inc. (PFE) scores 6.2/10 versus Aurora Cannabis Inc. (ACB) at 4.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: ACB or PFE?

Pfizer, Inc. (PFE) scores higher on Growth (5.1/10 vs 3.7/10). Aurora Cannabis Inc. reports revenue growth (5.1% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is ACB or PFE more attractively valued?

Pfizer, Inc. (PFE) scores higher on Valuation (7/10 vs 3.8/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about ACB vs PFE?

There are ACB with a consensus price target of N/A, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: ACB or PFE?

Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 2.1/10). Net profit margin: ACB at -42.4%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: ACB or PFE?

Aurora Cannabis Inc. (ACB) scores higher on Financial Health (7.7/10 vs 7/10). Market beta: ACB at 1.34, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of ACB and PFE?

Aurora Cannabis Inc. (ACB) has a market capitalisation of $181M, while Pfizer, Inc. (PFE) has a market cap of $147.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do ACB or PFE pay dividends?

ACB does not currently pay a dividend, while PFE pays a dividend yield of 6.61%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

JNJ vs PFEMRNA vs PFELLY vs PFE

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026